Control of an outbreak of BCG complications in Gaza

Daoud, W

doi:10.1046/j.1440-1843.2003.00489.x

Cited by 19 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Daoud showed regional lymphadenitis (61.3%), local abscess (21.3%), local ulcer (11.5%), keloid scar (5.3%) and disseminated disease (0.4%) were found as complications after BCG vaccine [20]. Our patients did not have any localized lymphadenopathy or disseminated BCG disease.…”

Section: Bcg Vaccine Complicationsmentioning

confidence: 49%

Local Cutaneous Complications After Bacille Calmette-Guerin Vaccine: Experience of a Single Center

et al. 2017

View full text Add to dashboard Cite

Background: Bacille Calmette-Guerin (BCG) vaccine may cause some cutaneous complications at the injection site. Although some of these are normal reactions, unexpected complications may be seen. Clinical features, treatment modalities and outcomes of these complications have not been clearly defined in literature. We aimed to determine the local cutaneous complications after BCG vaccine and clinical experiences in our hospital.

show abstract

Section: Bcg Vaccine Complicationsmentioning

confidence: 49%

Local Cutaneous Complications After Bacille Calmette-Guerin Vaccine: Experience of a Single Center

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Thus, the quantitative evolution of locoregional ADRs is representative of abscess evolution. Locoregional reactions after BCG vaccination, and in particular, abscesses, are well‐described in the literature . However, the percentage of abscesses reported in our study is higher than those found in the literature .…”

Section: Discussionmentioning

confidence: 91%

“…Locoregional reactions after BCG vaccination, and in particular, abscesses, are well‐described in the literature . However, the percentage of abscesses reported in our study is higher than those found in the literature . This may be explained by the fact that our follow‐up was based on spontaneous reports from health care professionals, who report the ADRs that seem most relevant to them.…”

Section: Discussionmentioning

confidence: 91%

Complications of BCG vaccine SSI® recent story and risk management plan: the French experience

Chol

Guy

Jacquet

et al. 2012

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

“…However, the use of a less virulent vaccine and proper vaccination techniques to minimize BCG complications is advised [54]. In addition, administration of BCG vaccine as an adjuvant immunotherapy against cancer is being widely implemented.…”

Section: Resultsmentioning

confidence: 99%

Update on cutaneous complications of Bacille Calmette-Guérin immunization

Attia¹

2012

Journal of the Egyptian Womenʼs Dermatologic Society

View full text Add to dashboard Cite

Bacille Calmette-Gué rin (BCG) is an attenuated form of Mycobacterium bovis that is used to offer protection against tuberculosis . Usually, 3-4 weeks after vaccination, an inflamed infiltrated papule appears, and then an ulcer develops, which heals by the 13th week. However, sometimes complications occur following BCG vaccination or immunotherapy, including cutaneous complications, which have been discussed in this review. Erythema, soreness, ulceration, blistering, keloid, BCG lymphadenitis, and inoculation site abscess occur frequently. Rare complications include complications directly related to vaccine components such as cold abscess of the chest wall, cutaneous granulomas (early and delayed), lupus vulgaris, sarcoidosis, and reactivation granulomatous skin lesions in patients with Kawasaki disease. Complications related to triggered immune response of the patient rather than to the vaccine itself include papular tuberculids, lichen scrofulosorum-like eruption, fixed drug eruption, and granuloma annulare. M. bovis infection of the penis, scrotal abscesses, Reiter's syndrome, and cryoglobulinemia vasculitis were reported during BCG intravesical immunotherapy. Intralesional BCG immunotherapy can induce lupus vulgaris, disseminated BCG, and erythema multiforme. In conclusion, BCG vaccination is to be promoted; however, the use of a less virulent vaccine and proper vaccination techniques to minimize BCG complications is advised. Proper selection of those receiving the vaccines should be considered.

show abstract

Control of an outbreak of BCG complications in Gaza

Cited by 19 publications

References 6 publications

Local Cutaneous Complications After Bacille Calmette-Guerin Vaccine: Experience of a Single Center

Local Cutaneous Complications After Bacille Calmette-Guerin Vaccine: Experience of a Single Center

Complications of BCG vaccine SSI® recent story and risk management plan: the French experience

Update on cutaneous complications of Bacille Calmette-Guérin immunization

Contact Info

Product

Resources

About